Skip to main content
Caplight Logo









LiGalli B.V.

LiGalli B.V.

Private
LeidenHealthcare & Life Scienceshttps://ligalli.health/

Last Round

VC Round

Sep 24, 2024

Total Funding Raised

$14.66M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

LiGalli B.V. is a medical technology company that develops the MedRing platform, a smart, personalized intravaginal drug delivery and diagnostic device for women's healthcare.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Precision Medicine, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

femtechdrug delivery deviceintravaginal deviceremote patient monitoringRPMprecision medicinehealth IoTsmart medical devicepatient compliancedigital healthconnected healthmedical device licensingclinical-stage biotechwearable health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LiGalli B.V. Comparables

Compare LiGalli B.V. with similar companies based on industry and business-model similarity.

LiGalli B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FemPulse Corporation
79%
AnelleO
68%
Organon & Co.
61%

LiGalli B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 24, 2024
Series BDec 30, 2021
Series AJun 30, 2020

Key People

Founding team and executive leadership

Marga Mathijssen

Chief Executive Officer

Executive Team

Thijs van Oorschot

Chief Technology Officer

Executive Team

Godert Vinkesteijn

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 103% MoM, reaching 2K.

  • May 14, 2026

    Monthly visitors grew 97% MoM, reaching 1.2K.

LiGalli B.V. Filings

Explore SEC and related filing metadata, where available.

LiGalli B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LiGalli B.V.'s valuation, stock price, and market status.

Is LiGalli B.V. a public or private company?

LiGalli B.V. is a private company.

What is the current stock price of LiGalli B.V.?

LiGalli B.V. is a private company with no public stock price. No recent secondary market data is available.

How much is LiGalli B.V. worth (valuation)?

Valuation information for LiGalli B.V. is not publicly available.

Can I buy LiGalli B.V. stock?

LiGalli B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LiGalli B.V.'s last funding round?

LiGalli B.V.'s most recent funding round was VC Round on September 24, 2024.

Who are the main investors in LiGalli B.V.?

Investor information for LiGalli B.V. is not publicly disclosed.

Will LiGalli B.V. IPO soon?

No public IPO plans have been announced for LiGalli B.V..

How can I track LiGalli B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LiGalli B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeiden
Employee Range13
Year Founded2014
Last FundingSep 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?